Compile Data Set for Download or QSAR
Report error Found 36 Enz. Inhib. hit(s) with all data for entry = 50044186 Sort by
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008271(CHEMBL3235132)
Affinity DataIC50: 8nMAssay Description:Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008279(CHEMBL3235140)
Affinity DataIC50: 41nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008272(CHEMBL3235133)
Affinity DataIC50: 41nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008278(CHEMBL3235139)
Affinity DataIC50: 66nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008271(CHEMBL3235132)
Affinity DataIC50: 76nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008273(CHEMBL3235134)
Affinity DataIC50: 80nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008269(CHEMBL3235130)
Affinity DataIC50: 87nMAssay Description:Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008272(CHEMBL3235133)
Affinity DataIC50: 100nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008274(CHEMBL3235135)
Affinity DataIC50: 106nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008273(CHEMBL3235134)
Affinity DataIC50: 117nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008275(CHEMBL3235136)
Affinity DataIC50: 124nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008269(CHEMBL3235130)
Affinity DataIC50: 400nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50226610((2S)-5-AMINO-2-[(1-PROPYL-1H-IMIDAZOL-4-YL)METHYL]...)
Affinity DataIC50: 450nMAssay Description:Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008276(CHEMBL3235137)
Affinity DataIC50: 585nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008270(CHEMBL3235131)
Affinity DataIC50: 620nMAssay Description:Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008271(CHEMBL3235132)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008278(CHEMBL3235139)
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50135933(3-(6-Amino-pyridin-3-yl)-2-(1H-imidazol-4-yl)-prop...)
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008277(CHEMBL3235138)
Affinity DataIC50: 2.27E+3nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008274(CHEMBL3235135)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008279(CHEMBL3235140)
Affinity DataIC50: 3.20E+3nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50226610((2S)-5-AMINO-2-[(1-PROPYL-1H-IMIDAZOL-4-YL)METHYL]...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008276(CHEMBL3235137)
Affinity DataIC50: 7.10E+3nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008270(CHEMBL3235131)
Affinity DataIC50: 8.00E+3nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008275(CHEMBL3235136)
Affinity DataIC50: 1.60E+4nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50135933(3-(6-Amino-pyridin-3-yl)-2-(1H-imidazol-4-yl)-prop...)
Affinity DataIC50: 3.10E+4nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase B2(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008277(CHEMBL3235138)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase N catalytic chain(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008271(CHEMBL3235132)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of carboxypeptidase N (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase N catalytic chain(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008272(CHEMBL3235133)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of carboxypeptidase N (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase N catalytic chain(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008273(CHEMBL3235134)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of carboxypeptidase N (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase N catalytic chain(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008274(CHEMBL3235135)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of carboxypeptidase N (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase N catalytic chain(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008275(CHEMBL3235136)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of carboxypeptidase N (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase N catalytic chain(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008276(CHEMBL3235137)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of carboxypeptidase N (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase N catalytic chain(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008277(CHEMBL3235138)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of carboxypeptidase N (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase N catalytic chain(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008278(CHEMBL3235139)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of carboxypeptidase N (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCarboxypeptidase N catalytic chain(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50008279(CHEMBL3235140)
Affinity DataIC50: 1.00E+6nMAssay Description:Inhibition of carboxypeptidase N (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
PubMed